Mounting evidence suggests that the IRE1α-mediated UPR branch could promote tumour development in glioblastoma by increasing the expression of genes associated with inflammation and angiogenesis, while loss-of-function mutations in the IRE1α signalling pathway increased the expression of matrix proteins, leading to inhibition of tumour invasion [89–93]. This evidence concerns the gene ERN1 and glioblastoma.